Download this white paper to learn about Celanese’s partnership with the drug development company Particle Sciences Inc. of Bethlehem, PA. Our partnership was designed to demonstrate the versatility of our EVA copolymers. Celanese commissioned Particle Sciences Inc. to use standard hot-melt processing to formulate EVA copolymers with two different vinyl acetate contents, and two different APIs. Through this process, we were able to develop drug eluting devices with molecules that have widely divergent characteristics.

Review this white paper for detailed background information for this experiment’s design, method and its results. You’ll learn more about our medical EVA copolymers’ exceptional versatility, and the comprehensive solutions they provide a wide range of controlled release drug delivery systems.